Market Overview:
The global autoimmune disorders treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of autoimmune diseases, technological advancements in the field of autoimmune disorders treatment, and rising awareness about autoimmune disorders. The global autoimmune disorders treatment market is segmented by type, application, and region. By type, the market is divided into bridge therapy, recombinant technology, fecal bacteriotherapy, hematopoietic stem-cell transplantation (HSCT), phototherapy, helminthic therapy (HT), and activation-induced assays (AIA). Bridge therapy refers to therapies that are used as a temporary measure until a permanent cure for an autoimmunity can be found; recombinant technology uses genetically modified cells or viruses to treat autoimmunity; fecal bacteriotherapy involves transferring healthy bacteria from one person into another person’s gut through stool transplantation in order to restore balance among gut microbiota; HSCT involves replacing diseased bone marrow with healthy stem cells from a donor; phototherapy uses light energy either alone or in combination with drugs to treat autoimmunity; HT uses parasitic worms living inside human intestines as treatments for various immune system problems such as Crohn’s disease and ulcerative colitis; AIA employs molecular techniques that detect specific proteins released by activated lymphocytes which helps identify which particular antigen has triggered an immune response.
Product Definition:
Autoimmune Disorders Treatment is the treatment of autoimmune diseases. Autoimmune diseases are a group of disorders in which the body's immune system attacks its own tissues and organs. The immune system is a collection of cells and organs that work together to protect the body from infection. It includes the white blood cells, which fight infection, and the thymus gland, which helps to produce white blood cells.
Bridge Therapy:
The global bridge therapy market is expected to witness lucrative growth over the forecast period owing to increasing incidences of autoimmune disorders such as rheumatoid arthritis, psoriasis and Crohn's disease. According to statistics published by the National Institute of Health (NIH), around 50 million people in America suffer from some form of autoimmune disorder.
Recombinant Technology:
Recombinant technology is a procedure that converts genes from one species to another. It's used in the treatment of various autoimmune disorders such as rheumatoid arthritis, lupus, and type-1 diabetes. The recombinant DNA molecule carries the gene for an enzyme that can replace the sick or damaged protein with healthy protein making its way into cells and tissues where it's needed.
Application Insights:
Systemic autoimmune diseases accounted for the largest share in 2017 and are expected to continue leading during the forecast period. This is due to a high prevalence of multiple sclerosis, rheumatoid arthritis, psoriasis, Crohn's disease and ulcerative colitis. The presence of such a large patient base with systemic autoimmune disorders is attributed to genetic susceptibility as well as environmental factors that trigger autoimmunity.
Localized autoimmune diseases are also anticipated to witness lucrative growth during the forecast period owing to an increase in awareness about these conditions coupled with advancements in treatment options over recent years. For instance, while phototherapy was once considered only for psoriasis patients who had failed all other treatments including medications and surgery; it has now been proven effective against various types of skin lesions caused by eczema or acne too (if severe).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of autoimmune disorders patient pool, advanced healthcare infrastructure and high adoption rate for novel treatment methods are some factors attributing to its largest share. In addition, increasing R&D investments by major companies is also expected to contribute towards this growth over the forecast period.
Asia Pacific is estimated to grow at a lucrative CAGR during the forecast period owing to rising disposable income levels and growing awareness about early diagnosis & treatment options in emerging countries such as China & India. Moreover, government initiatives aimed at improving access and coverage are expected to further boost regional market growth during the forecast period (2018-2030).
Growth Factors:
- Increasing incidence of autoimmune disorders
- Growing awareness about autoimmune disorders and their treatment options
- Rising demand for better and more effective treatments for autoimmune disorders
- Technological advancements in the field of autoimmune disorder treatment therapies
- Availability of government funding for research on new treatments for autoimmune disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Autoimmune Disorders Treatment Market Research Report
By Type
Bridge Therapy, Recombinant Technology, Fecal Bacteriotherapy, Hematopoietic Stem-cell Transplantation, Phototherapy, Helminthic Therapy, Activation-induced Assays
By Application
Systemic Autoimmune Diseases, Localized Autoimmune Diseases
By Companies
Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi, Merck, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Autoimmune Disorders Treatment Market Report Segments:
The global Autoimmune Disorders Treatment market is segmented on the basis of:
Types
Bridge Therapy, Recombinant Technology, Fecal Bacteriotherapy, Hematopoietic Stem-cell Transplantation, Phototherapy, Helminthic Therapy, Activation-induced Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Systemic Autoimmune Diseases, Localized Autoimmune Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthcare
- Johnson & Johnson
- Boehringer Ingelheim
- GlaxoSmithKline
- AstraZeneca
- Sanofi
- Merck
- Pfizer
Highlights of The Autoimmune Disorders Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bridge Therapy
- Recombinant Technology
- Fecal Bacteriotherapy
- Hematopoietic Stem-cell Transplantation
- Phototherapy
- Helminthic Therapy
- Activation-induced Assays
- By Application:
- Systemic Autoimmune Diseases
- Localized Autoimmune Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autoimmune Disorders Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autoimmune disorders treatment is a combination of medications, lifestyle changes, and other treatments that are used to help people with autoimmune disorders. Treatment may include medications such as corticosteroids or immunosuppressants, lifestyle changes such as eating a healthy diet and getting regular exercise, and other treatments such as radiation therapy or surgery.
Some of the major companies in the autoimmune disorders treatment market are Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi, Merck, Pfizer.
The autoimmune disorders treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autoimmune Disorders Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autoimmune Disorders Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autoimmune Disorders Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autoimmune Disorders Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autoimmune Disorders Treatment Market Size & Forecast, 2020-2028
4.5.1 Autoimmune Disorders Treatment Market Size and Y-o-Y Growth
4.5.2 Autoimmune Disorders Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bridge Therapy
5.2.2 Recombinant Technology
5.2.3 Fecal Bacteriotherapy
5.2.4 Hematopoietic Stem-cell Transplantation
5.2.5 Phototherapy
5.2.6 Helminthic Therapy
5.2.7 Activation-induced Assays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Systemic Autoimmune Diseases
6.2.2 Localized Autoimmune Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autoimmune Disorders Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autoimmune Disorders Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bridge Therapy
9.6.2 Recombinant Technology
9.6.3 Fecal Bacteriotherapy
9.6.4 Hematopoietic Stem-cell Transplantation
9.6.5 Phototherapy
9.6.6 Helminthic Therapy
9.6.7 Activation-induced Assays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Systemic Autoimmune Diseases
9.10.2 Localized Autoimmune Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bridge Therapy
10.6.2 Recombinant Technology
10.6.3 Fecal Bacteriotherapy
10.6.4 Hematopoietic Stem-cell Transplantation
10.6.5 Phototherapy
10.6.6 Helminthic Therapy
10.6.7 Activation-induced Assays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Systemic Autoimmune Diseases
10.10.2 Localized Autoimmune Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bridge Therapy
11.6.2 Recombinant Technology
11.6.3 Fecal Bacteriotherapy
11.6.4 Hematopoietic Stem-cell Transplantation
11.6.5 Phototherapy
11.6.6 Helminthic Therapy
11.6.7 Activation-induced Assays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Systemic Autoimmune Diseases
11.10.2 Localized Autoimmune Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bridge Therapy
12.6.2 Recombinant Technology
12.6.3 Fecal Bacteriotherapy
12.6.4 Hematopoietic Stem-cell Transplantation
12.6.5 Phototherapy
12.6.6 Helminthic Therapy
12.6.7 Activation-induced Assays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Systemic Autoimmune Diseases
12.10.2 Localized Autoimmune Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bridge Therapy
13.6.2 Recombinant Technology
13.6.3 Fecal Bacteriotherapy
13.6.4 Hematopoietic Stem-cell Transplantation
13.6.5 Phototherapy
13.6.6 Helminthic Therapy
13.6.7 Activation-induced Assays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Systemic Autoimmune Diseases
13.10.2 Localized Autoimmune Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autoimmune Disorders Treatment Market: Competitive Dashboard
14.2 Global Autoimmune Disorders Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Roche Diagnostics
14.3.3 Siemens Healthcare
14.3.4 Johnson & Johnson
14.3.5 Boehringer Ingelheim
14.3.6 GlaxoSmithKline
14.3.7 AstraZeneca
14.3.8 Sanofi
14.3.9 Merck
14.3.10 Pfizer
